Skip to main content
ANAB logo

ANAB · Anaptysbio, Inc · Debt

Track ANAB — free
$48.73 +0.63 (+1.31%) At close · Oct 23
Market Cap
$1.42B
Shares
29.10M
Volume · Oct 23 468.21K Avg daily vol (3M) 503.05K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Operating lease liabilities 2026-03-31 USD 13,613 10-Q filed 2026-05-12
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 2,120,000
Noncurrent operating lease liabilities
USD 11,493,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1370053 CUSIP 032724106 13F (30d) 19 filings 19 filers Visit website Investor relations